Azitra to Present at the ThinkEquity Conference
16 Outubro 2023 - 9:00AM
Business Wire
Azitra, Inc. (NYSE American: AZTR), a clinical-stage
biopharmaceutical company focused on developing innovative
therapies for precision dermatology, announced today that
management will present at the ThinkEquity Conference in New York
City on October 19 at 3:00pm ET. The presentation will be streamed
live and available for replay at:
https://wsw.com/webcast/tep24/aztr/1700335.
For more information about the conference or to schedule a
one-on-one in person meeting with management, contact your
conference representative or email James@HaydenIR.com.
ThinkEquity Conference – October 19, 2023
Format:
Azitra Inc., Corporate Presentation
Date/Time:
October 19th, 3:00 PM ET
Participant:
Francisco Salva, Chief Executive
Officer
Location:
Mandarin Oriental Hotel in New York
City
Webcast Link:
Register here
About Azitra, Inc.
Azitra, Inc. is an early-stage clinical biopharmaceutical
company focused on developing innovative therapies for precision
dermatology using engineered proteins and topical live
biotherapeutic products. The Company has built a proprietary
platform that includes a proprietary, microbial library of unique
bacterial strains that can be screened for therapeutic
characteristics and lead drug candidates. The platform is augmented
by an artificial intelligence and machine learning technology that
analyzes, predicts and helps screen the Company's library of
strains for drug like molecules. The Company's initial focus is on
the development of genetically engineered strains of Staphylococcus
epidermidis, or S. epidermidis, which the Company considers to be
an optimal therapeutic candidate species for engineering of
dermatologic therapies. For more information, please visit
https://azitrainc.com/.
Forward Looking Statements
This press release contains "forward-looking statements" that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as "anticipate," "believe," "contemplate," "could,"
"estimate," "expect," "intend," "seek," "may," "might," "plan,"
"potential," "predict," "project," "target," "aim," "should,"
"will" "would," or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on the Company's
current expectations and are subject to inherent uncertainties,
risks and assumptions that are difficult to predict. Further,
certain forward-looking statements are based on assumptions as to
future events that may not prove to be accurate. These and other
risks and uncertainties are described more fully in the section
titled "Risk Factors" in the final prospectus dated June 15, 2023
relating to our initial public offering filed with the SEC on June
21, 2023. Forward-looking statements contained in this announcement
are made as of this date, and the Company undertakes no duty to
update such information except as required under applicable
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231016175884/en/
Norman Staskey (203) 646-6446 staskey@azitrainc.com
James Carbonara Hayden IR (646)-755-7412 james@haydenir.com
Azitra (AMEX:AZTR)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Azitra (AMEX:AZTR)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024